Finnrick, an independent testing programme, publishes 14 assays for Qingdao Saber Technology Pharma QST: 10 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 4 did not. Most recent assay 3 Aug 2026.
Qingdao Saber Technology Pharma QST listed by Finnrick as "Trading", has no storefront on record — Finnrick lists only a messaging or social contact. Source: Finnrick, https://www.finnrick.com/vendors/qingdao-saber-technology-pharma-qst.
Finnrick-tested with poor results. Tested across 2 peptide products with 12 total samples.
Qingdao Saber Technology Pharma QST is listed as active. Finnrick Grade D. Finnrick avg score: 6.7/10 across 12 samples (2 products). Below-average quality. Exercise caution.
Qingdao Saber Technology Pharma QST holds independent lab grade D, assigned across 12 graded samples, average score 6.7/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
No independent third-party assay is on file for Qingdao Saber Technology Pharma QST, and we have not yet compiled a profile of its own website. An untested vendor has not failed a test — this is an absence of evidence, not evidence against it.
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 10 | 7 passed, 3 failed |
| Tirzepatide | 4 | 3 passed, 1 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | D (12 samples) |
| Average grader score | 6.7/10 |
| Vendor type | Research-use supplier |
Qingdao Saber Technology Pharma QST is listed as active and we hold 14 Finnrick assays (10 passing, 4 failing its purity threshold); an independent lab grade of D. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 14 assays for Qingdao Saber Technology Pharma QST: 10 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 4 did not. Most recent assay 3 Aug 2026.
Similar vendors: SwissChems, Bfflink, Reta-Peptide, HkRoids, Zenith Jove Peptide ZJ, Shanghai Baoju, Heman Peptide HM, Allen Biotechnology Co ABC.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Qingdao Sigma Chemical QSC Peptides Review, Qingdao VitaConin International Trading Peptides Review, Qingfuji Trading Peptides Review.